| Aqeel Abbas Gillani, MD | |
|
102 Park St, Cr Wood Cancer Center, Glens Falls, NY 12801-4403 | |
| (518) 926-6620 | |
| (518) 926-1954 |
| Full Name | Aqeel Abbas Gillani |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 30 Years |
| Location | 102 Park St, Glens Falls, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639167737 | NPI | - | NPPES |
| 02574963 | Medicaid | NY | |
| P00203086 | Other | NY | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 231997 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| High Peaks Hospice And Palliative Care, Inc | Saranac lake, NY | Hospice |
| Community Hospice, Inc, The | Rensselaer, NY | Hospice |
| Glens Falls Hospital | Glens falls, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Glens Falls Hospital Inc | 8325955974 | 152 |
News Archive
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat sources, to develop cell culture medium for use in exploration of alternative food sources derived from stem cells.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Waters Corporation reported fourth quarter 2009 sales of $429 million, an increase of 3% from sales of $418 million in the fourth quarter of 2008. In the quarter, foreign currency translation increased sales growth rate by 4% and on a currency neutral basis, sales decreased by 1% in comparison to the prior year's fourth quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.08, compared to $1.01 for the fourth quarter of 2008. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 5% to $1.12 from $1.07 in the fourth quarter of 2008.
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Researchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions.
› Verified 8 days ago
| Entity Name | Glens Falls Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336198217 PECOS PAC ID: 8325955974 Enrollment ID: O20031103000498 |
News Archive
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat sources, to develop cell culture medium for use in exploration of alternative food sources derived from stem cells.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Waters Corporation reported fourth quarter 2009 sales of $429 million, an increase of 3% from sales of $418 million in the fourth quarter of 2008. In the quarter, foreign currency translation increased sales growth rate by 4% and on a currency neutral basis, sales decreased by 1% in comparison to the prior year's fourth quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.08, compared to $1.01 for the fourth quarter of 2008. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 5% to $1.12 from $1.07 in the fourth quarter of 2008.
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Researchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aqeel Abbas Gillani, MD Po Box 304, Glens Falls, NY 12801-0304 Ph: (518) 926-6620 | Aqeel Abbas Gillani, MD 102 Park St, Cr Wood Cancer Center, Glens Falls, NY 12801-4403 Ph: (518) 926-6620 |
News Archive
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat sources, to develop cell culture medium for use in exploration of alternative food sources derived from stem cells.
Akela Pharma, Inc., a leader in the development of therapeutics for the treatment of pain, and the company's wholly owned subsidiary, PharmaForm, today announced its financial results for the three months and year ended December 31, 2010.
Waters Corporation reported fourth quarter 2009 sales of $429 million, an increase of 3% from sales of $418 million in the fourth quarter of 2008. In the quarter, foreign currency translation increased sales growth rate by 4% and on a currency neutral basis, sales decreased by 1% in comparison to the prior year's fourth quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.08, compared to $1.01 for the fourth quarter of 2008. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 5% to $1.12 from $1.07 in the fourth quarter of 2008.
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Researchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions.
› Verified 8 days ago
Robert William Sponzo, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 102 Park St, Cr Wood Cancer Center, Glens Falls, NY 12801 Phone: 518-926-6620 Fax: 518-926-1954 | |
Dr. Marcille Labban, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Park Street, Glens Falls Hospital - Hospitalist Program, Glens Falls, NY 12801 Phone: 518-926-5925 Fax: 518-926-5917 | |
Joseph Carlton Mihindukulasuriya, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 20 Murray Street, Glens Falls, NY 12801 Phone: 518-798-3838 Fax: 518-798-6125 | |
Ovais Ahmed, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Irongate Ctr, Glens Falls, NY 12801 Phone: 518-793-5034 | |
Dr. Eric Anthony Pillemer, M.D., PH.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 102 Park St, Glens Falls, NY 12801 Phone: 518-926-6620 Fax: 518-926-1954 | |
Dr. Michael Chase, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Irongate Ctr, Glens Falls, NY 12801 Phone: 518-793-5034 | |
Dr. Stephen Anthony Monn, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 92 Broad St, Glens Falls, NY 12801 Phone: 518-793-9055 |